Ceia F, Silva-Pinto A, Carvalho A C, Piñeiro C, Soares J, Serrão R, Sarmento A
Infectious Diseases Department, Centro Hospitalar São João, Porto, University of Porto, Portugal.
Faculty of Medicine, University of Porto, University of Porto, Portugal.
Open Forum Infect Dis. 2019 Feb 12;6(4):ofz063. doi: 10.1093/ofid/ofz063. eCollection 2019 Apr.
Dual human immunodeficiency virus (HIV) 1 and HIV-2 superinfections are rare but challenging. A HIV-1-infected patient receiving effective antiretroviral therapy was investigated for a severe CD4 cell count decline. HIV-2 superinfection was diagnosed and genotypic test revealed mutations conferring resistance to most drug class, limiting options for treatment.
人类免疫缺陷病毒(HIV)1型和HIV - 2型双重感染罕见但具有挑战性。一名接受有效抗逆转录病毒治疗的HIV - 1感染患者因CD4细胞计数严重下降而接受调查。诊断为HIV - 2重叠感染,基因检测显示存在对大多数药物类别耐药的突变,限制了治疗选择。